Closing the Gap Between Humans and AI with Ursula Tavender and Dagmar Albers

In the next episode of The Human Protocol, Theodora Savlovschi-Wicks is joined by Ursula Tavender and Dagmar Albers, co-founders of Innovation In. Ursula and Dagmar work with SMEs on people-first AI transformation, helping leaders make sense of a fast-moving and often overwhelming shift in how work, decision-making, and performance are evolving. In this conversation, they explore why AI adoption is still so uneven, what organisations get wrong when they bolt tools onto old systems, and why clarity, curiosity, visibility, and judgment matter more than ever. We talk about resistance to change, shadow AI, leadership uncertainty, self-advocacy, performance reviews, and the growing risk of valuing speed over quality. We also explore what future-proofing really looks like for professionals in a world where technical skills alone are no longer enough. This episode is a thoughtful conversation about the future of work, the human skills AI cannot replace, and why people-first transformation has to begin with leadership clarity. Key takeaways 🔸 Why resistance to AI is often really fear, uncertainty, and lack of clarity🔸 Why leaders need to define what AI is actually for before adoption can work🔸 Why working hard with your head down is no longer enough for career growth🔸 Why speed is not the same as performance in an AI-enabled workplace🔸 Why curiosity, adaptability, visibility, and judgment matter more than ever🔸 Why people-first AI transformation starts with better questions, not just better tools Host: Theodora Savlovschi-WicksFounder and Managing Director, Vivexa PartnersLinkedIn: https://www.linkedin.com/in/theoswicks/ Guest: Ursula TavenderCo-Founder at Innovation InLinkedIn: https://www.linkedin.com/in/ursula-tavender/ Guest: Dagmar AlbersCo-Founder at Innovation InLinkedIn: https://www.linkedin.com/in/dagmar-albers/ The Human Protocol is a podcast from Vivexa, exploring clinical conversations at the intersection of people and trials. 🔔 Subscribe for more conversations on the people shaping clinical research and the future of work.